Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
06/2003
06/25/2003EP1321772A1 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/25/2003EP1076654B1 Method for the continuous production of 1,3-dioxolan-2-ones
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426384A Method for producing ketal and/or acetal
06/24/2003US6583306 Forming dioxolane derivative of citramalic acid; replacing free carboxylic acid with leaving group; coupling with hydroxyl, amino, thiol, sulphinyl or sulphonyl reactive compound; deprotecting; amidation with aniline derivitive
06/24/2003US6583161 Benzenesulfonamides and benzamides as therapeutic agents
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050092A2 Process for the preparation of tofisopam and new intermediates
06/19/2003WO2003049690A2 Hiv integrase inhibitors
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318824A1 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
06/18/2003EP1318803A1 Fatty acid synthase inhibitors
06/18/2003EP0907631B1 Inorganic ion receptor-active compounds
06/17/2003US6579987 Diaryl-enynes
06/17/2003CA2060710C Process for preparing 1,3-dioxols
06/12/2003WO2003048112A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation
06/12/2003CA2466570A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317439A1 Acid-sensitive compounds, preparation and uses thereof
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003CN1422844A Intermediate for preparing substitated biphenyl oxazoline compounds
06/10/2003US6576781 Reacting aglycone intermediate with methanesulfonic acid to form pseudopterosin compound
06/10/2003US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor
06/05/2003WO2003045898A1 Prodrugs of excitatory amino acids
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2002091988A3 Novel processes for the preparation of adenosine compounds and intermediates thereto
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0862545B1 Pesticide compounds, compositions and process for the preparation thereof
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/04/2003CN1110478C Biocidal benzylbiphenyl derivatives
06/03/2003US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
06/03/2003US6573284 Method of treating melanoma
05/2003
05/30/2003WO2003044065A2 Microstructure modifier for anionic polymerization
05/30/2003WO2003035595A8 Novel norbornane and norbornene derivatives, use thereof and perfumed products containing same.
05/29/2003US20030100776 Allows for substitution of functional groups within the olefin without comprising efficiency of metathesis
05/28/2003EP1313754A1 Nucleophile-stable thioester generating compounds, methods of production and use
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/28/2003CN1109499C Fungicide active substance combinations
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569810 Cyclopentane-1,3-dione derivatives
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042153A1 Difluoroalkene derivative and pest control agent containing the same
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1071656B1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same
05/21/2003CN1419536A Process for the selective N-formylation of n-hydroxylamines
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109029C oxygenic heterocyclic compounds
05/20/2003US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation
05/20/2003US6566550 Substituted aromatic ethers as inhibitors of glycine transport
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/15/2003WO2003040121A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003US20030092769 Diaryl-enynes
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 183